Yahoo Web Search

Search results

  1. Anne E. Wojcicki (/ w uː ˈ tʃ ɪ t s k i / woo-CHITS-kee; born July 28, 1973) is an American entrepreneur who co-founded and is CEO of the personal genomics company 23andMe. She founded the company in 2006 with Linda Avey and Paul Cusenza.

  2. www.forbes.com › profile › anne-wojcickiAnne Wojcicki - Forbes

    Jun 1, 2023 · Anne Wojcicki is the cofounder and CEO of 23andMe, a pioneering direct-to-consumer genetics testing firm based in South San Francisco, California. In June 2021, 23andMe went public in...

  3. May 20, 2021 · Anne Wojcicki, CEO of 23andMe, spent a decade in healthcare and biotechnology before launching the DNA testing and analysis company in 2006.

  4. Anne Wojcicki. CEO and Co-Founder. Anne co-founded 23andMe in 2006, three years after the first human genome was sequenced. Her goal was audacious: to help people access, understand, and benefit from the human genome and fundamentally change healthcare in the process.

  5. View Anne Wojcickis profile on LinkedIn, a professional community of 1 billion members. Experience: 23andMe · Location: Mountain View · 500+ connections on LinkedIn.

  6. Jun 17, 2021 · Anne Wojcicki, the cofounder and CEO of 23andMe, owns 99.4 million shares of the merged company; with shares trading on the Nasdaq under the ticker “ME” at $13.40 as of 3:00pm EDT...

  7. Apr 25, 2023 · Genetics have the potential to transform how we predict, prevent, and treat almost all human disease, writes 23andMe CEO Anne Wojcicki.

  8. Dec 7, 2021 · Anne Wojcicki, Chief Executive Officer of 23andMe, photographed for Forbes by Aaron Kotowski in June 2019. Aaron Kotowski/The Forbes Collection. The cofounder and CEO of 23andMe spoke to...

  9. Sep 20, 2021 · My guest today is Anne Wojcicki. She’s the CEO of 23andMe. Over 12 million people have forked over $100 or more for the company’s DNA test, where you spit into a vial, mail the vial into the ...

  10. We are a mission-driven company with big dreams of using data to revolutionize health, wellness, and research.